Thomas Gajewski to Transplantation, Autologous
This is a "connection" page, showing publications Thomas Gajewski has written about Transplantation, Autologous.
Connection Strength
0.019
-
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas. Leuk Lymphoma. 2010 Jul; 51(7):1241-50.
Score: 0.019